Anuh Pharma Surges Amid Broader Market Decline, Highlighting Small-Cap Resilience

Anuh Pharma, a small-cap player in the Pharmaceuticals & Biotechnology sector, has shown significant activity today, gaining 12.48% as of May 19, 2025. This performance notably outpaces the broader market, with the stock outperforming the Sensex by 10.93%. Over the past two days, Anuh Pharma has recorded a cumulative return of 12.83%, indicating a positive trend in its recent performance.
The stock reached an intraday high of Rs 204.7, reflecting a 13.25% increase at its peak. However, it has also exhibited high volatility today, with an intraday fluctuation of 5%. Anuh Pharma is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a strong short-term momentum.

In the context of the overall market, the Sensex has experienced a decline of 0.33% today, moving further away from its 52-week high. Despite this, small-cap stocks, including Anuh Pharma, are leading the market, with the BSE Small Cap index gaining 0.75%. Over the past month, Anuh Pharma has outperformed the Sensex significantly, with a 1-month return of 18.51% compared to the Sensex's 4.46%.